Evaluation and Management of Pain in Autosomal Dominant Polycystic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 17, Issue 3, 2010, Pages

  Hogan, Marie C ^a   Norby, Suzanne M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autosomal dominant; Flank pain; Polycystic kidney; Polycystic kidney disease complications

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CLONIDINE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; LEVORPHANOL; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PARACETAMOL PLUS TRAMADOL; PREGABALIN; SALICYLIC ACID; TRAMADOL;

ACUPUNCTURE ANALGESIA; ADJUVANT THERAPY; ALTERNATIVE MEDICINE; ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT DISORDER; CHRONIC PAIN; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG HALF LIFE; FENESTRATION; HEMATURIA; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY DENERVATION; KIDNEY HEMORRHAGE; KIDNEY INFECTION; KIDNEY PAIN; KIDNEY POLYCYSTIC DISEASE; KIDNEY SURGERY; LABORATORY TEST; LAPAROSCOPIC SURGERY; LIVER CYST; LIVER PAIN; LIVER SURGERY; LOW DRUG DOSE; NEPHRECTOMY; NEPHROLITHIASIS; NEUROPATHIC PAIN; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PAIN ASSESSMENT; PANCREAS DISEASE; PATHOGENESIS; PATIENT COMPLIANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PYELONEPHRITIS; RECOMMENDED DRUG DOSE; REVIEW; SATIETY; SCLEROTHERAPY; SPINAL CORD STIMULATION; SURGICAL APPROACH; TRANSCUTANEOUS NERVE STIMULATION; UROGENITAL TRACT DISEASE;

ACUPUNCTURE; CHRONIC DISEASE; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER; PAIN; PANCREAS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RENAL ARTERY; SURGICAL PROCEDURES, OPERATIVE;

EID: 77951597493     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2010.01.005     Document Type: Review

References (88)

1. Bajwa Z.H., Gupta S., Warfield C.A., and Steinman T. Pain management in polycystic kidney disease. Kidney Int 60 (2001) 1631-1644
2. Bajwa Z.H., Sial K.A., Malik A.B., and Steinman T.I. Pain patterns in patients with polycystic kidney disease. Kidney Int 66 (2004) 1561-1569
3. Dalgaard O.Z. Bilateral polycystic disease of the kidneys: A follow-up of two hundred and eighty-four patients and their families. Acta Med Scand 328 suppl (1957) 1-255
4. Gabow P.A. Autosomal dominant polycystic kidney disease-more than a renal disease. Am J Kidney Dis 16 (1990) 403-413
5. Grantham J.J. Renal pain in polycystic kidney disease: When the hurt won't stop. J Am Soc Nephrol 2 (1992) 1161-1162
6. Iglesias C.G., Torres V.E., Offord K.P., Holley K.E., Beard C.M., and Kurland L.T. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 2 (1983) 630-639
7. Segura J.W., King Jr. B.F., Jowsey S.G., Martin P., and Zince H. Chronic pain and its medical and surgical management in renal cystic diseases. In: Torres V.E., and Watson M.L. (Eds). Polycystic Kidney Disease (1996), Oxford University, New York, NY 462-480
8. Clarke K.A., and Iphofen R. A phenomenological hermeneutic study into unseen chronic pain. Br J Nurs 17 (2008) 658-663
9. Heiwe S., and Bjuke M. "An evil heritage": Interview study of pain and autosomal dominant polycystic kidney disease. Pain Management Nursing 10 (2009) 134-141
10. Torres V.E., Harris P.C., and Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 369 (2007) 1287-1301
11. Rizk D., Jurkovitz C., Veledar E., et al. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis. Clin J Am Soc Nephrol 4 (2009) 560-566
12. Ansell J, Gee W, d B.J, Diseases of the kidney and ureter. In the management of pain (2nd edition) (ed J Bonica) Vol. 2 pp 1232-49. Lea & Febiger, Philadelphia, PA, in The management of pain., B. J, Editor. 1990, Lea & Febiger: Philadelphia, PA. p. 1232-1249.
13. Naidoo N., Partab P., Pather N., Moodley J., Singh B., and Satyapal K.S. Thoracic splanchnic nerves: implications for splanchnic denervation. J Anat 1995 (2001) 585-590
14. Brown J.A., Torres V.E., King B.F., and Segura J.W. Laparoscopic marsupialization of symptomatic polycystic kidney disease. J Urol 156 (1996) 22-27
15. Bennett W.M., and Elzinga L.W. Clinical management of autosomal dominant polycystic kidney disease. Kidney Int Suppl 42 (1993) S74-S79
16. Ravich L., Lerman P.H., and Drabkin J. Ruptured renal cyst in polycystic disease. Urology 7 (1976) 60-61
17. Tarrass F., and Benjelloun M. Acute abdomen caused by spontaneous renal cyst rupture in an ADPKD haemodialysed patient. Nephrology 13 (2008) 177-178
18. Gupta S., Seith A., Sud K., et al. CT in the evaluation of complicated autosomal dominant polycystic kidney disease. Acta Radiol 41 (2000) 280-284
19. Nishiura J.L., Neves R.F., Eloi S.R., Cintra S.M., Ajzen S.A., and Heilberg I.P. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 4 (2009) 838-844
20. Sallee M., Rafat C., Zahar J.-R., et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4 (2009) 1183-1189
21. Yuki K., Takeshi S., and Akito T. Diagnosis and localization of infected renal cyst by diffusion-weighted magnetic resonance imaging in polycystic kidney disease. Int J Urol 16 (2009) 918-919
22. Bleeker-Rovers C.P., de Sevaux R.G., van Hamersvelt H.W., Corstens F.H., and Oyen W.J. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 41 (2003) E18-E21
23. Soussan M., Sberro R., Wartski M., Fakhouri F., Pecking A.P., and Alberini J.L. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease. Ann Nucl Med 22 (2008) 529-531
24. Torres V.E., Erickson S.B., Smith L.H., Wilson D.M., Hattery R.R., and Segura J.W. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11 (1988) 318-325
25. Torres V.E., Wilson D.M., Hattery R.R., and Segura J.W. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22 (1993) 513-519
26. Grampsas S.A., Chandhoke P.S., Fan J., et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36 (2000) 53-57
27. Keith D.S., Torres V.E., King B.F., Zincki H., and Farrow G.M. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 4 (1994) 1661-1669
28. Bae K.T., Zhu F., Chapman A.B., et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease Cohort. Clin J Am Soc Nephrol 1 (2006) 64-69
29. Vauthey J.N., Maddern G.J., and Blumgart L.H. Adult polycystic disease of the liver. Br J Surg 78 (1991) 524-527
30. Nicolau C., Torra R., Bianchi L., et al. Abdominal sonographic study of autosomal dominant polycystic kidney disease. J Clin Ultrasound 28 (2000) 277-282
31. Torra R., Nicolau C., Badenas C., et al. Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. Clin Nephrol 47 (1997) 19-22
32. NiMhaille B.A., Norby S.M., Rosetti S., et al. Pancreatic cysts and intraductal papillary mucinous neoplasms in ADPKD. J Am Soc Nephrol 19 (2008) 126A
33. Malka D., Hammel P., Vilgrain V., Flejou J.F., Belghiti J., and Bernades P. Chronic obstructive pancreatitis due to a pancreatic cyst in a patient with autosomal dominant polycystic kidney disease. Gut 42 (1998) 131-134
34. Sato Y., Mukai M., Sasaki M., et al. Intraductal papillary-mucinous neoplasm of the pancreas associated with polycystic liver and kidney disease. Pathol Int 59 (2009) 201-204
35. Telenti A., Torres V.E., Gross Jr. J.B., Van Scoy R.E., Brown M.L., and Hattery R.R. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 65 (1990) 933-942
36. Little P., Lewith G., Webley F., et al. Randomised controlled trial of Alexander technique lessons, exercise, and massage (ATEAM) for chronic and recurrent back pain. BMJ 337 (2008) 884
37. Hall D. Bad backs-Uncovering the real problem: The Alexander technique sheds light on a sore situation. Lamp 45 (1988) 24-28
38. Nam T.S., Baik E.J., Shin Y.U., Jeong Y., and Paik K.S. Mechanism of transmission and modulation of renal pain in cats; effects of transcutaneous electrical nerve stimulation on renal pain. Yonsei Med J 36 (1995) 187-201
39. Mora B., Giorni E., Dobrovits M., et al. Transcutaneous electrical nerve stimulation: An effective treatment for pain caused by renal colic in emergency care. J Urol 175 (2006) 1737-1741
40. Brennan F., Carr D.B., and Cousins M. Pain management: a fundamental human right. Anesth Analg 105 (2007) 205-221
41. Gourlay D.L., Heit H.A., and Almahrezi A. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med 6 (2005) 107-112
42. Chou R., Ballantyne J.C., Fanciullo G.J., Fine P.G., and Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 10 (2009) 147-159
43. Chou R., Fanciullo G.J., Fine P.G., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10 (2009) 113-130
44. Argoff C.E., and Silvershein D.I. A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: Tailoring therapy to meet patient needs. Mayo Clin Proc 84 (2009) 602-612
45. Sasaki K., Smith C.P., Chuang Y.C., Lee J.Y., Kim J.C., and Chancellor M.B. Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol 7 (2001) 47-49
46. Gabapentin In:, in DRUGDEX® Evaluations. 2010, Thompson
47. Brinkhaus B., Witt C.M., Jena S., et al. Acupuncture in patients with chronic low back pain: a randomized controlled trial. Arch Intern Med 166 (2006) 450-457
48. Haake M., Muller H.H., Schade-Brittinger C., et al. German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch Intern Med 167 (2007) 1892-1898
49. Cherkin D.C., Sherman K.J., Avins A.L., et al. A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch Intern Med 169 (2009) 858-866
50. MacPherson H., Green G., Nevado A., et al. Brain imaging of acupuncture: comparing superficial with deep needling. Neurosci Lett 434 (2008) 144-1449
51. Bennett W.M., Elzinga L., Golper T.A., and Barry J.M. Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol 137 (1987) 620-622
52. Lee D.I., Andreoni C.R., Rehman J., et al. Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: Impact on pain, hypertension, and renal function. J Endourol 17 (2003) 345-354
53. Lifson B.J., Teichman J.M., and Hulbert J.C. Role and long-term results of laparoscopic decortication in solitary cystic and autosomal dominant polycystic kidney disease. J Urol 159 (1998) 702-705
54. Elzinga L.W., Barry J.M., Torres V.E., et al. Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2 (1992) 1219-1226
55. Casale P., Meyers K., and Kaplan B. Follow-up for laparoscopic renal denervation and nephropexy for autosomal dominant polycystic kidney disease-related pain in pediatrics. J Endourol 22 (2008) 991-993
56. Resnick M., Chang A.Y., and Casale P. Laparoscopic renal denervation and nephropexy for autosomal dominant polycystic kidney disease related pain in adolescents. J Urol 175 (2006) 2274-2276
57. Valente J.F., Dreyer D.R., Breda M.A., and Bennett W. Laparoscopic renal denervation for intractable ADPKD-related pain. Nephrol Dial Transplant 16 (2001) 160
58. Chapuis O., Sockeel P., Pallas G., Pons F., and Jancovici R. Thoracoscopic renal denervation for intractable autosomal dominant polycystic kidney disease-related pain. Am J Kidney Dis 43 (2004) 161-163
59. Leksowski K. Thoracoscopic splanchnicectomy for the relief of pain due to chronic pancreatitis. Surg Endosc 15 (2001) 592-596
60. Greenwell T.J., Peters J.L., Neild G.H., and Shah PJ.. The outcome of renal denervation for managing loin pain haematuria syndrome. BJU Int 93 (2004) 818-821
61. Hogan M. Evaluation of Videothoracoscopic Renal Denervation for Intractable Autosomal Dominant Polycystic Kidney Disease-Related Pain (2009), ASN, San Diego, CA
62. Binsaleh S., Luke P.P., Nguan C., and Kapoor A. Comparison of laparoscopic and open nephrectomy for adult polycystic kidney disease: operative challenges and technique. Can J Urol 13 (2006) 3340-3345
63. Lipke M.C., Bargman V., Milgrom M., and Sundaram C.P. Limitations of laparoscopy for bilateral nephrectomy for autosomal dominant polycystic kidney disease. J Urol 177 (2007) 627
64. Ubara Y., Katori H., Tagami T., et al. Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis. Am J Kidney Dis 34 (1999) 926-931
65. Ubara Y., Tagami T., Sawa N., et al. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kidney Dis 39 (2002) 571-579
66. Schnelldorfer T., Torres V.E., Zakaria S., Rosen C.B., and Nagorney D.M. Polycystic liver disease: A critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 250 (2009) 112-118
67. Que F., Nagorney D.M., Gross Jr. J.B., and Torres V.E. Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology 108 (1995) 487-494
68. Takei R., Ubara Y., Hoshino J., et al. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 49 (2007) 744-752
69. Park H.C., Kim C.W., Ro H., et al. Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients. J Korean Med Sci 24 (2009) 57-61
70. Dimitrakov J. A road map to biomarker discovery and validation in urological chronic pelvic pain syndrome. J Urol 179 (2008) 1660-1661
71. Hewitt S.M., Dear J., and Star R.A. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 15 (2004) 1677-1689
72. Chapman A.T., VE, Perrone R., Steinman T., et al. The HALT Polycystic Kidney Disease Trials: Design and Implementation. C J A S N (2010)
73. Akinci D., Turkbey B., Yilmaz R., Akpinar E., Ozmen M., and Akhan O. Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease. Cardiovasc Interv Radiol 31 (2008) 926-930
74. Akinci D., Akhan O., Ozmen M., et al. Long-term results of single-session percutaneous drainage and ethanol sclerotherapy in simple renal cysts. Eur J Radiol 54 (2005) 298-302
75. Lee Y.R., and Lee K.B. Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease. Korean J Radiol 4 (2003) 239-242
76. Uemasu J., Fujihara M., Munemura C., Nakamura E., and Kawasaki H. Cyst sclerotherapy with minocycline hydrochloride in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 11 (1996) 843-846
77. Kim S.H., Moon M.W., Lee H.J., Sim J.S., Kim S.H., and Ahn C. Renal cyst ablation with n-butyl cyanoacrylate and iodized oil in symptomatic patients with autosomal dominant polycystic kidney disease: Preliminary report. Radiology 226 (2003) 573-576
78. Uemasu J., Fujiwara M., Munemura C., Tokumoto A., and Kawasaki H. Effects of topical instillation of minocycline hydrochloride on cyst size and renal function in polycystic kidney disease. Clin Nephrol 39 (1993) 140-144
79. Singh I., and Mehrotra G. Selective ablation of symptomatic dominant renal cysts using 99% ethanol in adult polycystic kidney disease. Urology 68 (2006) 482-487
80. Kim S.H., and Cho J.Y. Cyst ablation using a mixture of N-butyl cyanoacrylate and iodized oil in patients with autosomal dominant polycystic kidney disease: the long-term results. Korean J Radiol 10 (2009) 377-383
81. Sakuhara Y., Kato F., Abo D., et al. Transcatheter arterial embolization with absolute ethanol injection for enlarged polycystic kidneys after failed metallic coil embolization. J Vasc Interv Radiol 19 (2008) 267-271
82. Masue N., Katoh S., Itoh S., et al. Renal transcatheter arterial embolization for autosomal dominant polycystic kidney disease: Report of two cases. Hinyokika Kiyo 51 (2005) 741-745
83. Rehman J., Landman J., Andreoni C., McDougall E.M., and Clayman R.V. Laparoscopic bilateral hand assisted nephrectomy for autosomal dominant polycystic kidney disease: Initial experience. J Urol 166 (2001) 42-47
84. Jenkins M.A., Crane J.J., and Munch L.C. Bilateral hand-assisted laparoscopic nephrectomy for autosomal dominant polycystic kidney disease using a single midline HandPort incision. Urology 59 (2002) 32-36
85. Bendavid Y., Moloo H., Klein L., et al. Laparoscopic nephrectomy for autosomal dominant polycystic kidney disease. Surg Endosc 18 (2004) 751-754
86. Desai P.J., Castle E.P., Daley S.M., et al. Bilateral laparoscopic nephrectomy for significantly enlarged polycystic kidneys: A technique to optimize outcome in the largest of specimens. Br J Urol 101 (2008) 1019-1023
87. Desai M.R., Nandkishore S.K., Ganpule A., and Thimmegowda M. Pretransplant laparoscopic nephrectomy in adult polycystic kidney disease: A single centre experience. Br J Urol 101 (2008) 94-97
88. Binsaleh S., Al-Enezi A., Dong J., and Kapoor A. Laparoscopic nephrectomy with intact specimen extraction for polycystic kidney disease. J Endourol 22 (2008) 675-680